The FDA approval includes a box label warning about the drug’s known side effects, which include brain swelling and tiny bleeds.
Alzheimer’s Medicine
The Food and Drug Administration of America on Thursday 2 November approved the drug Lecanemab for people with early Alzheimer’s disease, making it easier for older adults to get the first drug proven to slow memory and thinking problems.
By , in North America, World, Health · 11 Nov 2023, 16:31 · 0 Comments











